Obesity in Diabetes
Open Access
- 1 September 1966
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 19 (3) , 158-162
- https://doi.org/10.1093/ajcn/19.3.158
Abstract
The effect on weight loss of regularity and frequency of attendance at a diabetic clinic over a period of six months was studied in fifty obese diabetic patients. In addition, a double-blind controlled trial of long-acting, intermittently administered diethylpropion (Tenuate Dospan) was undertaken. Forty patients completed the trial, the mean total weight loss achieved by these patients was 11.7 pounds. Twenty-three patients who had attended the clinic intermittently before this investigation had significantly greater weight losses when they attended regularly. There was no significant difference in the weight loss achieved by those attending every three weeks when compared to the weight loss achieved by those attending every five weeks. Diethylpropion was more effective than placebo in helping obese diabetic patients to lose weight during the periods when tablets were taken. However, during the periods when tablets were not taken the patients who had been given the placebo continued to lose weight whereas those who had been given diethylpropion did not. Thus there was a marked difference in the overall pattern of weight loss between the two groups. These findings are discussed and some suggestions for treatment made.This publication has 5 references indexed in Scilit:
- The Long‐Term Management of Obesity in General PracticeInternational Journal Of Clinical Practice, 1965
- A DOUBLE-BLIND STUDY OF DIETHYLPROION IN OBESITYThe Lancet Healthy Longevity, 1961
- Diethylpropion in the Treatment of "Refractory" ObesityBMJ, 1961
- The treatment of obesity: An analysis of methods, results, and factors which influence successJournal of Chronic Diseases, 1960
- The Results of Treatment for ObesityA.M.A. Archives of Internal Medicine, 1959